1991
DOI: 10.1016/0165-2427(91)90122-s
|View full text |Cite
|
Sign up to set email alerts
|

Antigen specificity and activity of ovine antibodies induced by immunization with Corynebacterium pseudotuberculosis culture filtrate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0
3

Year Published

1993
1993
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 20 publications
1
14
0
3
Order By: Relevance
“…These molecular masses may correspond to those of the phospholipase D exotoxin of C. pseudotuberculosis (Carne, 1940) and of the CP40 antigen previously described by Walker et al (1994). Most infected animals sera also recognised proteins of 26, 37, 63 and 67 kDa which were previously described (Ellis et al, 1991b;Braithwaite et al, 1993). It is noteworthy to stress on the high and persistent immunoreactivity of both 63 and 67 kDa antigens.…”
Section: Discussionsupporting
confidence: 68%
“…These molecular masses may correspond to those of the phospholipase D exotoxin of C. pseudotuberculosis (Carne, 1940) and of the CP40 antigen previously described by Walker et al (1994). Most infected animals sera also recognised proteins of 26, 37, 63 and 67 kDa which were previously described (Ellis et al, 1991b;Braithwaite et al, 1993). It is noteworthy to stress on the high and persistent immunoreactivity of both 63 and 67 kDa antigens.…”
Section: Discussionsupporting
confidence: 68%
“…Este fato sugere que este fator de virulência contra o qual muitos trabalhos de proteção vacinal têm sido elaborados (Ellis et al 1991, Tachedjian et al 1995, Hodgson et al 1999, mantém uma homogeneidade nas suas características genéticas, permitindo assim que a resposta imune desenvolvida contra a PLD possa ser explorada como instrumento de controle da doença também na região estudada.…”
Section: Resultsunclassified
“…Therefore, attempts to control CLA usually entail immunoprophylaxis by vaccination. Various strategies have been used for developing vaccines against CLA, including the use of inactivated or attenuated C. pseudotuberculosis strains [4,5], fractions of bacterial cells containing bacterial antigens, antigens from culture supernatants, and DNA vaccines [6]. None of the currently commercially available vaccines for C. pseudotuberculosis provide effective protection against CLA [7].…”
Section: Resultsmentioning
confidence: 99%